News
EBS
7.63
-0.78%
-0.06
Weekly Report: what happened at EBS last week (0706-0710)?
Weekly Report · 5d ago
Federal health role nominee has record of vaccine skepticism, Stat News reports
TipRanks · 07/10 19:51
Weekly Report: what happened at EBS last week (0629-0703)?
Weekly Report · 07/06 09:54
'White House Adds Pandemic Response Staff as Ebola Cases Rise' - Bloomberg News
Benzinga · 07/01 16:19
Emergent BioSolutions Secures New ACAM2000 Biodefense Contract
TipRanks · 06/29 15:28
Emergent BioSolutions awarded $52.7M contract modification
TipRanks · 06/29 13:25
Emergent BioSolutions Secures $52.7M U.S. Government Contract Modification For ACAM2000 Smallpox And Mpox Vaccine Supply
Benzinga · 06/29 13:13
Weekly Report: what happened at EBS last week (0622-0626)?
Weekly Report · 06/29 09:51
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
Barchart · 06/29 08:13
CDC Raises Its Response Level To Congo Ebola Outbreak To Level 1 Activation, Its Highest Level; Says Risk Of Ebola Spreading In The U.S. Remains Low
Benzinga · 06/26 17:10
Weekly Report: what happened at EBS last week (0615-0619)?
Weekly Report · 06/22 09:57
Weekly Report: what happened at EBS last week (0608-0612)?
Weekly Report · 06/15 09:58
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Seeking Alpha · 06/08 21:27
Weekly Report: what happened at EBS last week (0601-0605)?
Weekly Report · 06/08 09:55
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
Barchart · 06/04 07:02
These 10 small-cap U.S. healthcare giants rank among the market's most attractively valued stocks
Seeking Alpha · 06/01 14:20
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Emergent Biosolutions (EBS) and Compass Therapeutics (CMPX)
TipRanks · 06/01 10:30
Weekly Report: what happened at EBS last week (0525-0529)?
Weekly Report · 06/01 09:58
Emergent BioSolutions Gets $64.5M Contract Modification From HHS for Botulism Treatment
Dow Jones · 05/28 21:02
Emergent BioSolutions awarded $64.5M HHS contract modification
TipRanks · 05/28 21:00
More
Webull provides a variety of real-time EBS stock news. You can receive the latest news about Emergent Biosolutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.